TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 DKK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
682
|
1,059
|
995 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
-29
|
307
|
233 |
| EBITDA |
-29
|
307
|
234 |
| Total assets |
349
|
589
|
513 |
| Current assets |
276
|
589
|
513 |
| Current liabilities |
-38
|
3
|
40 |
| Equity capital |
333
|
510
|
413 |
| - share capital |
68
|
63
|
66 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
95.4%
|
86.6%
|
80.5% |
| Turnover per employee |
341
|
530
|
498 |
| Profit as a percentage of turnover |
-4.3%
|
29.0%
|
23.4% |
| Return on assets (ROA) |
-8.3%
|
52.3%
|
45.6% |
| Current ratio |
-726.3%
|
19633.3%
|
1282.5% |
| Return on equity (ROE) |
-8.7%
|
60.2%
|
56.4% |
| Change turnover |
-453
|
100
|
-111 |
| Change turnover % |
-40%
|
10%
|
-10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.